Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease - HIJ-CREATE

Description:

The goal of the trial was to evaluate treatment with the angiotensin receptor blocker candesartan compared with standard therapy without an angiotensin receptor blocker in patients with coronary artery disease and hypertension.